Which artery is used to screen for fetal anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Screening for Fetal Anemia: Middle Cerebral Artery

The middle cerebral artery (MCA) is the vessel used to screen for fetal anemia, not the umbilical artery. 1, 2

Why MCA and Not Umbilical Artery

  • The MCA peak systolic velocity (MCA-PSV) is the primary screening method recommended by the Society for Maternal-Fetal Medicine for detecting fetal anemia of any etiology, including red cell alloimmunization, parvovirus infection, twin-twin transfusion syndrome, and fetomaternal hemorrhage. 1, 2

  • Umbilical artery Doppler does not reliably reflect fetal anemia because velocity changes in this vessel are not consistently related to hemoglobin levels; instead, umbilical artery Doppler primarily assesses placental resistance and is used for conditions such as placental insufficiency and fetal growth restriction. 2

Diagnostic Performance of MCA-PSV

  • MCA-PSV detects moderate to severe fetal anemia with nearly 100% sensitivity (95% CI: 0.86-1.0) and a false-positive rate of approximately 12%. 1, 3

  • A threshold of MCA-PSV >1.5 multiples of the median (MoM) signals significant risk of severe fetal anemia and warrants fetal blood sampling with preparation for possible intrauterine transfusion. 1, 2

  • MCA-PSV outperforms amniocentesis for anemia diagnosis; amniotic fluid delta OD450 should not be used for this purpose. 2, 4

Physiologic Basis

  • As fetal hemoglobin decreases, MCA-PSV increases due to compensatory hyperdynamic circulation, allowing determination of hemoglobin values with good approximation in moderate to severe anemia. 1

  • The technique is universally applicable regardless of the underlying cause of anemia, providing a versatile screening tool across multiple etiologies. 1, 2, 4

Proper Measurement Technique

Location and visualization:

  • Measure at the proximal MCA, approximately 2 mm distal to its origin from the internal carotid artery, which yields excellent reproducibility (intraclass correlation 0.98-0.99). 2
  • Obtain an axial section of the fetal head at the level of the sphenoid bones and image the circle of Willis with color Doppler. 1
  • The entire length of the MCA should be visualized, occupying more than 50% of the image after zooming. 1

Technical parameters:

  • Align the ultrasound beam as close to 0° as possible, parallel to the artery for its entire length, ideally without angle correction. 1, 2
  • Acquire measurements during fetal quiescence (no breathing or movements) to minimize heart-rate-related velocity variation. 1, 2
  • Perform at least three consecutive measurements and record the highest MCA-PSV value for clinical decision-making. 1, 2

Clinical Application

  • The procedure takes approximately 5-10 minutes when performed by trained operators. 1

  • Operators must be properly trained in the technique, as incorrect use by inexperienced personnel may cause more harm than good; patients at risk should be referred to centers with trained sonographers. 4

  • Serial measurements (trends) may decrease the false-positive rate to less than 5%, compared to single measurements. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Middle Cerebral Artery Peak Systolic Velocity as the Primary Screening Tool for Fetal Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Middle cerebral artery peak systolic velocity: is it the standard of care for the diagnosis of fetal anemia?

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.